Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Principal Financial Group Inc.

Principal Financial Group Inc. increased its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) by 4.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 257,733 shares of the company’s stock after purchasing an additional 10,306 shares during the quarter. Principal Financial Group Inc. owned 0.56% of Pacira BioSciences worth $4,856,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Pacer Advisors Inc. boosted its holdings in Pacira BioSciences by 129.4% in the third quarter. Pacer Advisors Inc. now owns 4,962,221 shares of the company’s stock valued at $74,681,000 after purchasing an additional 2,799,434 shares in the last quarter. State Street Corp increased its position in shares of Pacira BioSciences by 5.8% in the third quarter. State Street Corp now owns 2,014,012 shares of the company’s stock valued at $30,311,000 after buying an additional 110,162 shares in the last quarter. Impax Asset Management Group plc raised its stake in shares of Pacira BioSciences by 81.0% during the 3rd quarter. Impax Asset Management Group plc now owns 470,603 shares of the company’s stock worth $7,083,000 after buying an additional 210,576 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Pacira BioSciences by 4.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 431,897 shares of the company’s stock valued at $6,500,000 after purchasing an additional 16,819 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its position in Pacira BioSciences by 269.7% during the third quarter. BNP Paribas Financial Markets now owns 395,695 shares of the company’s stock worth $5,955,000 after buying an additional 288,662 shares in the last quarter. Institutional investors and hedge funds own 99.73% of the company’s stock.

Pacira BioSciences Trading Down 4.5 %

NASDAQ:PCRX opened at $22.96 on Tuesday. The stock has a market cap of $1.06 billion, a price-to-earnings ratio of -11.31 and a beta of 0.80. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.89 and a current ratio of 2.25. The business has a fifty day moving average of $23.23 and a 200-day moving average of $18.74. Pacira BioSciences, Inc. has a 1 year low of $11.16 and a 1 year high of $31.67.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on PCRX shares. Royal Bank of Canada restated a “sector perform” rating and set a $18.00 target price on shares of Pacira BioSciences in a research report on Tuesday, January 14th. HC Wainwright upped their target price on Pacira BioSciences from $57.00 to $70.00 and gave the stock a “buy” rating in a research report on Friday. Truist Financial raised shares of Pacira BioSciences from a “sell” rating to a “hold” rating and lifted their price target for the stock from $8.00 to $25.00 in a research note on Thursday, January 30th. Needham & Company LLC increased their target price on Pacira BioSciences from $30.00 to $32.00 and gave the company a “buy” rating in a research note on Friday. Finally, Barclays boosted their price target on Pacira BioSciences from $17.00 to $24.00 and gave the company an “overweight” rating in a report on Friday. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $27.22.

About Pacira BioSciences

Pacira Biosciences, Inc is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.